SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-046227
Filing Date
2024-02-26
Accepted
2024-02-26 16:27:18
Documents
6
Effectiveness Date
2024-02-26

Document Format Files

Seq Description Document Type Size
1 S-8 d730348ds8.htm S-8 40999
2 EX-5.1 d730348dex51.htm EX-5.1 6997
3 EX-23.1 d730348dex231.htm EX-23.1 1689
4 EX-FILING FEES d730348dexfilingfees.htm EX-FILING FEES 22894
5 GRAPHIC g730348g04x74.jpg GRAPHIC 6046
6 GRAPHIC g730348g28t15.jpg GRAPHIC 9682
  Complete submission text file 0001193125-24-046227.txt   95622
Mailing Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158
Business Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Filer) CIK: 0001706431 (see all company filings)

IRS No.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-277358 | Film No.: 24679336
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)